ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

    Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

    Applications
    | 2022 | Thermo Fisher Scientific
    ICP/MS, ICP/OES
    Instrumentation
    ICP/MS, ICP/OES
    Manufacturer
    Thermo Fisher Scientific
    Industries
    Pharma & Biopharma

    Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

    Applications
    | 2016 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Determination of Extractable and Leachable Elements Using ICP-MS

    Applications
    | 2022 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

    Applications
    | 2023 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

    Applications
    | 2022 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products

    Posters
    | 2012 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

    Applications
    | 2019 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Characterization of Rare Earth Elements used for Radiolabeling Applications by ICP-QQQ

    Applications
    | 2020 | Agilent Technologies
    ICP/MS, ICP/MS/MS
    Instrumentation
    ICP/MS, ICP/MS/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    End-To-End Spectroscopy-Based Workflow Solutions for Oligonucleotide Analysis

    Brochures and specifications
    | 2023 | Agilent Technologies
    GC, GC/MSD, HeadSpace, GC/SQ, Software, HPLC, RAMAN Spectroscopy, UV–VIS spectrophotometry, ICP/MS, FTIR Spectroscopy
    Instrumentation
    GC, GC/MSD, HeadSpace, GC/SQ, Software, HPLC, RAMAN Spectroscopy, UV–VIS spectrophotometry, ICP/MS, FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

    Applications
    | 2020 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma
     

    Related content


    The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

    Mo, 6.5.2024
    Mestrelab Research

    Who is Martin Pumera, one of the most cited scientists in the world?

    Mo, 6.5.2024
    CEITEC

    Webinars LabRulezICPMS Week 19/2024

    Su, 5.5.2024
    LabRulez
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike